WE-E-BRB-08: Establishing Comprehensive Quality Assurance Program for Volumetric Modulated Arc Therapy - Clinical Study Using Control Point Analysis Software

2012 ◽  
Vol 39 (6Part27) ◽  
pp. 3957-3957
Author(s):  
Y Rong ◽  
J Jia ◽  
J Sun ◽  
N Gupta
Keyword(s):  
Quality Assurance ◽  
Clinical Study ◽  
Control Point ◽  
Volumetric Modulated Arc Therapy ◽  
Quality Assurance Program ◽  
Analysis Software ◽  
Point Analysis ◽  
Arc Therapy

Quality assurance of volumetric modulated arc therapy using Elekta Synergy

2009 ◽  
pp. 1-5 ◽  
Author(s):  
Akihiro Haga ◽  
Keiichi Nakagawa ◽  
Kenshiro Shiraishi ◽  
Saori Itoh ◽  
Atsuro Terahara ◽  
...  
Keyword(s):  
Quality Assurance ◽  
Volumetric Modulated Arc Therapy ◽  
Arc Therapy

scholarly journals Physical dosimetry of volumetric modulated arc therapy (VMAT) using EPID and 2D array for quality assurance

2018 ◽  
Vol 49 (2) ◽  
pp. 477-484
Author(s):  
Ismail E. Mohamed ◽  
Ayman G. Ibrahim ◽  
Hamdy M. Zidan ◽  
Hesham S. El-Bahkiry ◽  
Adel Y. El-sahragti
Keyword(s):  
Quality Assurance ◽  
Volumetric Modulated Arc Therapy ◽  
Arc Therapy ◽  
2D Array

scholarly journals Positional Accuracy and Quality Assurance of Backup JAWs Required for Volumetric Modulated Arc Therapy

2012 ◽  
Vol 68 (11) ◽  
pp. 1486-1491
Author(s):  
Daisaku Tatsumi ◽  
Ryosei Nakada ◽  
Akinori Ienaga ◽  
Akane Yomoda ◽  
Makoto Inoue ◽  
...  
Keyword(s):  
Quality Assurance ◽  
Volumetric Modulated Arc Therapy ◽  
Positional Accuracy ◽  
Arc Therapy

scholarly journals Time-Resolved Versus Integrated Transit Planar Dosimetry for Volumetric Modulated Arc Therapy

2016 ◽  
Vol 15 (6) ◽  
pp. NP79-NP87 ◽  
Author(s):  
L.C.G.G. Persoon ◽  
M. Podesta ◽  
S.M.J.J.G. Nijsten ◽  
E.G.C. Troost ◽  
F. Verhaegen
Keyword(s):  
Computed Tomography ◽  
Pleural Effusion ◽  
Tumor Regression ◽  
Control Point ◽  
Volumetric Modulated Arc Therapy ◽  
Time Resolved ◽  
Treatment Dose ◽  
Arc Therapy ◽  
Geometrical Change ◽  
Radiation Treatments

Purpose: It is desirable that dosimetric deviations during radiation treatments are detected. Integrated transit planar dosimetry is commonly used to evaluate external beam treatments such as volumetric-modulated arc therapy. This work focuses on patient geometry changes which result in differences between the planned and the delivered radiation dose. Integrated transit planar dosimetry will average out some deviations. Novel time-resolved transit planar dosimetry compares the delivered dose of volumetric-modulated arc therapy to the planned dose at various time points. Four patient cases are shown where time-resolved transit planar dosimetry detects patient geometry changes during treatment. Methods: A control point to control point comparison between the planned dose and the treatment dose of volumetric-modulated arc therapy beams is calculated using the planning computed tomography and the kV cone-beam computed tomography of the day and evaluated with a time-resolved γ function. Results were computed for 4 patients treated with volumetric-modulated arc therapy, each showing an anatomical change: pleural effusion, rectal gas pockets, and tumor regression. Results: In all cases, the geometrical change was detected by time-resolved transit planar dosimetry, whereas integrated transit planar dosimetry showed minor or no indication of the dose discrepancy. Both tumor regression cases were detected earlier in the treatment with time-resolved planar dosimetry in comparison to integrated transit planar dosimetry. The pleural effusion and the gas pocket were detected exclusively with time-resolved transit planar dosimetry. Conclusions: Clinical cases were presented in this proof-of-principle study in which integrated transit planar dosimetry did not detect dosimetrically relevant deviations to the same extent time-resolved transit planar dosimetry was able to. Time-resolved transit planar dosimetry also provides results that can be presented as a function of arc delivery angle allowing easier interpretation compared to integrated transit planar dosimetry.

Quality assurance of volumetric-modulated arc therapy head and neck cancer treatment using PRESAGE® dosimeter

2018 ◽  
Vol 17 (4) ◽  
pp. 441-446 ◽  
Author(s):  
Jalil ur Rehman ◽  
Muhammad Isa ◽  
Nisar Ahmad ◽  
H. M. Noor ul Huda Khan Asghar ◽  
Zaheer A. Gilani ◽  
...  
Keyword(s):  
Quality Assurance ◽  
Cancer Treatment ◽  
Head And Neck ◽  
Treatment Planning ◽  
Volumetric Modulated Arc Therapy ◽  
Planning System ◽  
Treatment Planning System ◽  
Ct Scans ◽  
Arc Therapy ◽  
Calculated Dose

AbstractBackgroundAccurate three-dimensional dosimetry is essential in modern radiotherapy techniques such as volumetric-modulated arc therapy (VMAT) and intensity-modulated radiation therapy (IMRT). In this research work, the PRESAGE® dosimeter was used as quality assurance (QA) tool for VMAT planning for head and neck (H&N) cancer.Material and methodComputer tomography (CT) scans of an Image Radiation Oncology Core (IROC) H&N anthropomorphic phantom with both IROC standard insert and PRESAGE® insert were acquired separately. Both CT scans were imported into the Pinnacle (9.4 version) TPS for treatment planning, where the structures [planning target volume (PTV), organs at risk) and thermoluminescent detectors (TLDs) were manually contoured and used to optimise a VMAT plan. Treatment planning was done using VMAT (dual arc: 182°–178°, 178°–182°). Beam profile comparisons and gamma analysis were used to quantify agreement with film, PRESAGE® measurement and treatment planning system (TPS) calculated dose distribution.ResultsThe average ratio of TLD measured to calculated doses at the four PTV locations in the H&N phantom were between 0·95 to 0·99 for all three VMAT deliveries. Dose profiles were taken along the left–right, the anterior–posterior and superior–inferior axes, and good agreement was found between the PRESAGE® and Pinnacle profile. The mean value of gamma results for three VMAT deliveries in axial and sagittal planes were found to be 94·24 and 93·16% when compared with film and Pinnacle, respectively. The average values comparing the PRESAGE® results and dose values calculated on Pinnacle were observed to be 95·29 and 94·38% in the said planes, respectively, using a 5%/3 mm gamma criteria.ConclusionThe PRESAGE® dose measurements and calculated dose of pinnacle show reasonable agreement in both axial and sagittal planes for complex dual arc VMAT treatment plans. In general, the PRESAGE® dosimeter is found to be a feasible QA tool of VMAT plan for H&N cancer treatment.

Sign in / Sign up

Export Citation Format

Share Document